News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
151,685 Results
Type
Article (5553)
Company Profile (77)
Press Release (146055)
Section
Business (52835)
Career Advice (254)
Deals (10569)
Drug Delivery (20)
Drug Development (11802)
Employer Resources (29)
FDA (3287)
Job Trends (3890)
News (78768)
Policy (5269)
Tag
Academia (597)
Alliances (16226)
Alzheimer's disease (196)
Approvals (3281)
Artificial intelligence (66)
Bankruptcy (31)
Best Places to Work (3291)
Biotechnology (54)
Breast cancer (29)
Cancer (210)
Career advice (223)
Cell therapy (53)
Clinical research (9120)
Collaboration (139)
Compensation (29)
COVID-19 (383)
C-suite (25)
Data (159)
Diabetes (24)
Diagnostics (2092)
Earnings (16525)
Employer resources (25)
Events (19885)
Executive appointments (87)
FDA (3399)
Featured Employer (20)
Funding (74)
Gene editing (20)
Gene therapy (32)
GLP-1 (91)
Government (607)
Healthcare (4930)
Infectious disease (391)
Inflammatory bowel disease (26)
Interviews (34)
IPO (3578)
Job creations (648)
Job search strategy (198)
Layoffs (62)
Legal (1049)
Lung cancer (30)
Manufacturing (52)
Medical device (3526)
Medtech (3528)
Mergers & acquisitions (7085)
Metabolic disorders (44)
Neuroscience (248)
NextGen Class of 2024 (1802)
Non-profit (891)
Northern California (381)
Opinion (30)
Patents (20)
People (16157)
Phase I (3209)
Phase II (3979)
Phase III (3037)
Pipeline (48)
Postmarket research (301)
Preclinical (1371)
Press Release (32)
Radiopharmaceuticals (59)
Rare diseases (22)
Real estate (1660)
Regulatory (3824)
Research institute (649)
Resumes & cover letters (35)
Southern California (279)
Startups (994)
United States (2743)
Vaccines (57)
Date
Today (29)
Last 7 days (197)
Last 30 days (692)
Last 365 days (9211)
2024 (7807)
2023 (10261)
2022 (12962)
2021 (14593)
2020 (14045)
2019 (12911)
2018 (9714)
2017 (7863)
2016 (7133)
2015 (7856)
2014 (5675)
2013 (4661)
2012 (5328)
2011 (5560)
2010 (4622)
Location
Africa (143)
Arizona (26)
Asia (10727)
Australia (1108)
California (754)
Canada (261)
China (76)
Colorado (39)
Connecticut (22)
Europe (19653)
Florida (90)
Georgia (20)
Illinois (84)
Indiana (70)
Kansas (28)
Maryland (114)
Massachusetts (438)
Michigan (45)
Minnesota (62)
New Jersey (194)
New York (132)
North Carolina (220)
Northern California (381)
Ohio (53)
Pennsylvania (100)
South America (235)
Southern California (279)
Texas (86)
Utah (20)
Washington State (57)
151,685 Results for "integrated biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Integrated Biosciences Joins Illumina Ventures Labs to Design Novel Therapeutics Targeting the Transcriptome
Integrated Biosciences today announced they have joined Illumina Ventures Labs to integrate the company’s drug discovery engine with Illumina sequencing.
May 28, 2024
·
3 min read
Genetown
Tome Biosciences Presented Data on its Programmable Genomic Integration Technologies at ASGCT
Tome Biosciences, Inc., the programmable genomic integration company, presented preclinical data highlighting its progress in developing PGI as integrative gene and cell therapies at ASGCT’s 27th Annual Meeting in Baltimore, MD.
May 10, 2024
·
3 min read
Press Releases
Integrated Biosciences Raises $17 Million to Accelerate Development of Drugs Targeting Age-Related Diseases
October 3, 2024
·
6 min read
Biotech Bay
Integrated Biosciences Partners with Project 8p Foundation to Pioneer a New Path to Groundbreaking Treatments for Chromosomal Disorders
Integrated Biosciences announced a strategic partnership with the patient-led Project 8p Foundation to enhance the treatment landscape for chromosome 8p duplication, deletion and inverted duplication deletion disorders.
April 23, 2024
·
4 min read
Genetown
Tome Biosciences to Present Data on Programmable Genomic Integration Technologies at ASGCT
Tome Biosciences, Inc. today announced that it will present preclinical data on its PGI technologies, integrase-mediated PGI (I-PGI) and ligase-mediated PGI (L-PGI), at ASGCT’s 27th Annual Meeting taking place May 7-11 in Baltimore, MD.
April 23, 2024
·
2 min read
Genetown
Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform
Tome Biosciences, Inc., the programmable genomic integration company, has launched to usher in a new era of genomic medicines based on programmable genomic integration.
December 12, 2023
·
4 min read
Genetown
Sanguine Biosciences Adds Advanced Health Data Integration Capabilities that Further Enhance Translational Medical Research
Sanguine Biosciences announced advanced capabilities in acquiring and integrating electronic health records with donor specimens, further advancing its commitment to empowering patients to participate in medical research.
January 8, 2024
·
3 min read
Business
Integrated DNA Technologies and Element Biosciences Accelerate Next Generation Sequencing Workflows for Element’s AVITI™ System
Life sciences companies Integrated DNA Technologies (IDT) and Element Biosciences, Inc. have bolstered their partnership with products to enable more efficient and streamlined next generation sequencing (NGS) workflows for users of the AVITI System, an innovative sequencing and multi-omics platform based on Element’s novel avidity base chemistry.
February 5, 2024
·
5 min read
Genetown
Tome Biosciences Announces US Patent Issued for Integrase-Mediated Programmable Genomic Integration
Tome Biosciences, Inc. today announces the issuance of US Patent 11,952,571 for “Systems, Methods, and Compositions for Site-Specific Genetic Engineering Using Programmable Addition via Site-Specific Targeting Elements (PASTE)” by the US Patent and Trademark Office.
April 9, 2024
·
1 min read
Business
Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud’s, Forward Integrating PBIO’s UltraShear Platform into Multiple Markets
Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud’s, Forward Integrating PBIO’s UltraShear Platform into Multiple Markets.
January 11, 2024
·
8 min read
1 of 15,169
Next